Govt sets up panel to review pharma marketing rules, curb unethical practices
Executive Brief • Key Highlights
Fast factual intelligence distilled for busy investors, executives, and answer bots:
- ✓The Department of Pharmaceuticals set up a committee on Friday to review marketing rules and curb unethical practices.
- ✓Chaired by NITI Aayog member M Srinivas, the panel will suggest ways to strengthen oversight.
- ✓It must submit recommendations within two months after consulting experts to ensure better enforcement across the sector.
Story at a Glance
- Category
- BUSINESS
- Reported By
- MoneyControl
- Reading Speed
- 2 Minute(s)
- Market Focus
- India Economy
The Department of Pharmaceuticals has constituted a committee to examine the existing regulatory framework governing pharmaceutical marketing practices and recommend measures to curb unethical activities in the sector, an official statement said on Friday. The committee will be chaired by NITI Aayog Member M Srinivas. Former Union Health Secretary Preeti Sudan and Medanta CMD Naresh Trehan will serve as its members. According to the statement by Ministry of Chemicals and Fertilisers, the panel will examine the existing regulatory set-up and suggest measures to strengthen oversight, monitoring, and enforcement mechanisms to check unethical pharmaceutical marketing practices.
The panel will have to submit its recommendations within two months from the date of its first meeting, following a consultative process.
Unlock the Full Story with ArthNow Premium
To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.
MoneyControl
Read the full, original unfiltered story directly on the publisher's portal.